Cargando…
Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
OBJECTIVE: Incident type 2 diabetes is common among patients with recent acute coronary syndrome and is associated with an adverse prognosis. Some data suggest that cholesteryl ester transfer protein (CETP) inhibitors reduce incident type 2 diabetes. We compared the effect of treatment with the CETP...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171952/ https://www.ncbi.nlm.nih.gov/pubmed/32144166 http://dx.doi.org/10.2337/dc19-2204 |